2 transcripts
DVAX
Earnings call transcript
NASDAQ
2023 Q4
22 Feb 24
of flexibility in identifying the right asset for Dynavax. So Kelly, why don't you provide some commentary on our overall capital allocation strategy?
Sure
DVAX
Earnings call transcript
NASDAQ
2023 Q2
3 Aug 23
to include therapeutic modalities outside of vaccines.
We remain focused on disciplined capital allocation strategy and our efforts to generate
- Prev
- 1
- Next